Trial Details

Not Recruiting
Basic Information
Clinical ID c2992
Identifier EUCTR2015-003310-24-SE
Trial Title A Phase 3, Open-label, Randomized, Prospective Clinical Trial Evaluating the Efficacy of Stratified Treatment with Ursodeoxycholic Acid (UDCA) in Preventing Hepatobiliary and Colorectal Malignancy in Surveillance Patients with Primary Sclerosing Cholangitis (PSC) - UDCAPSCSURV
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions Primary sclerosing cholangitis with or without concomitant inflammatory bowel disease included in an unlimited surveillance program for hepatobiliary and colorectal malignancy;Therapeutic area: Diseases [C] - Cancer [C04]
Interventions Trade Name: Ursofalk Product Name: Ursofalk Pharmaceutical Form: Capsule, hard
Participant Information
Sponsor Sahlgrenska Academy
City -
Country/Region Sweden
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE3
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -